Expertise in
65
conditions

Dr. Syed F. Zafar

Hematology | Oncology
Florida Cancer Specialists Pl
8260 Gladiolus Dr, 
Fort Myers, FL 
Accepting New Patients
Offers Telehealth
Expertise in
65
conditions
Florida Cancer Specialists Pl
8260 Gladiolus Dr, 
Fort Myers, FL 

Overview

Syed Zafar is a Hematologist and an Oncologist practicing medicine in Fort Myers, Florida.

Dr. Zafar is highly rated in 65 conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Lung Cancer, Paget Disease of the Breast, and Familial Colorectal Cancer.

Dr. Zafar is board certified in American Board Of Internal Medicine. He is actively involved in clinical research, co-authoring 8 peer reviewed articles and participating in 3 clinical trials. Dr. Zafar is currently accepting new patients.

Specialties

Hematology
Oncology

Licenses

Internal Medicine in FL

Board Certifications

American Board Of Internal Medicine

Fellowships

Emory University Hospital , Internal Medicine

Hospital Affiliations

Cape Coral Hospital
Gulf Coast Medical Center Lee Health
Lee Memorial Hospital
Lee Memorial Hospital

Languages Spoken

English
Hindi
Urdu

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alliant Health
  • HMO
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
AvMed
  • HMO
  • POS
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
Capital District Physicians Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Florida Blue
  • EPO
  • PPO
Freedom Health
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Options
  • HMO
  • POS
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Simply Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
Sunshine Health
  • EPO
  • HMO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 23 Less Insurance Carriers -

Locations

Florida Cancer Specialists Pl
8260 Gladiolus Dr, Fort Myers, FL 33908
Other Locations
Florida Cancer Specialists Pl
1030 Commerce Creek Blvd, Cape Coral, FL 33909
Florida Cancer Specialists Pl
1708 Cape Coral Pkwy W Ste 10, Cape Coral, FL 33914

Additional Areas of Focus

Dr. Zafar has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Metastatic Uveal Melanoma

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Randomized, Double-Blind, Phase 2 Study of Ramucirumab or Merestinib or Placebo Plus Cisplatin and Gemcitabine as First-Line Treatment in Patients With Advanced or Metastatic Biliary Tract Cancer
Randomized, Double-Blind, Phase 2 Study of Ramucirumab or Merestinib or Placebo Plus Cisplatin and Gemcitabine as First-Line Treatment in Patients With Advanced or Metastatic Biliary Tract Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 22, 2026
Intervention Type: Drug
Study Phase: Phase 2
A Phase III, Multicenter, Open-Label, Randomized Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Pomalidomide and Dexamethasone (B-Pd) Versus Pomalidomide Plus Bortezomib and Dexamethasone (PVd) in Participants With Relapsed/Refractory Multiple Myeloma (DREAMM 8)
A Phase III, Multicenter, Open-Label, Randomized Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Pomalidomide and Dexamethasone (B-Pd) Versus Pomalidomide Plus Bortezomib and Dexamethasone (PVd) in Participants With Relapsed/Refractory Multiple Myeloma (DREAMM 8)
Enrollment Status: Active_not_recruiting
Publish Date: June 12, 2026
Intervention Type: Drug
Study Drugs: Belantamab Mafodotin, Pomalidomide, Dexamethasone, Bortezomib
Study Phase: Phase 3
A Phase 3, Randomized Study of Zanubrutinib (BGB-3111) Compared With Ibrutinib in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
A Phase 3, Randomized Study of Zanubrutinib (BGB-3111) Compared With Ibrutinib in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Enrollment Status: Completed
Publish Date: March 30, 2025
Intervention Type: Drug
Study Drugs: Zanubrutinib, Ibrutinib
Study Phase: Phase 3
View 2 Less Clinical Trials

8 Total Publications

Zanubrutinib is well tolerated and effective in patients with CLL/SLL intolerant of ibrutinib/acalabrutinib: updated results.
Zanubrutinib is well tolerated and effective in patients with CLL/SLL intolerant of ibrutinib/acalabrutinib: updated results.
Journal: Blood advances
Published: December 02, 2024
Similar Doctors
Expertise in
31
conditions
Dr. Lowell L. Hart
Hematology | Oncology
Expertise in
31
conditions
Dr. Lowell L. Hart
Hematology | Oncology
Referral may be required

Florida Cancer Specialists Pl

8260 Gladiolus Dr, 
Fort Myers, FL 
 (0.1 miles away)
239-437-5755
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Lowell Hart is a Hematologist and an Oncologist practicing medicine in Fort Myers, Florida. Dr. Hart is highly rated in 31 conditions, according to our data. His clinical expertise encompasses Breast Cancer, Lung Cancer, Inflammatory Breast Cancer, and Paget Disease of the Breast. Dr. Hart is board certified in American Board Of Internal Medicine. Dr. Hart is currently accepting new patients.

Expertise in
22
conditions
Dr. William N. Harwin
Hematology | Oncology
Expertise in
22
conditions
Dr. William N. Harwin
Hematology | Oncology
Referral may be required

Florida Cancer Specialists P L

15681 New Hampshire Ct, 
Fort Myers, FL 
 (0.6 miles away)
239-437-4444
Languages Spoken:
English
See accepted insurances

William Harwin is a Hematologist and an Oncologist practicing medicine in Fort Myers, Florida. Dr. Harwin is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Paget Disease of the Breast, Inflammatory Breast Cancer, Lung Cancer, and Pleuropulmonary Blastoma.

Expertise in
21
conditions
Dr. Vanrajsinh G. Rana
Hematology | Oncology
Expertise in
21
conditions
Dr. Vanrajsinh G. Rana
Hematology | Oncology
Referral may be required

Florida Cancer Specialists P L

4371 Veronica S Shoemaker Blvd, 
Fort Myers, FL 
 (6.3 miles away)
239-274-8200
Languages Spoken:
English
See accepted insurances

Vanrajsinh Rana is a Hematologist and an Oncologist practicing medicine in Fort Myers, Florida. Dr. Rana is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Febrile Neutropenia, and Nasopharyngeal Carcinoma.

Frequently Asked Questions about Dr. Syed F. Zafar

How do I make an appointment with Dr. Syed F. Zafar?

You can book an appointment with Dr. Syed F. Zafar by calling their office at 239-437-5755. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Syed F. Zafar a top-rated expert for Pleuropulmonary Blastoma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Syed F. Zafar is classified as an Distinguished expert for Pleuropulmonary Blastoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Syed F. Zafar specialize in?

While Dr. Syed F. Zafar is a Hematology, they have specific expertise in Pleuropulmonary Blastoma, Lung Cancer, and Paget Disease of the Breast. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Syed F. Zafar participate in research or clinical trials?

Yes. Dr. Syed F. Zafar has published 8 articles and abstracts on conditions like Pleuropulmonary Blastoma. You can view a list of Dr. Syed F. Zafar's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Syed F. Zafar accept my insurance?

Dr. Syed F. Zafar accepts most major insurance plans, including Aetna and Alliant Health. We recommend calling the office directly at 239-437-5755 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Zafar's expertise for a condition
ConditionClose
    View All 13 Distinguished Conditions
    View All 52 Advanced Conditions
    View All 89 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile